A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab

Tumor necrosis factor-alpha antagonism is an important treatment strategy in patients with rheumatoid arthritis, psoriatic arthritis, vasculitis, and ankylosing spondylitis. Adalimumab is one of the well-known tumor necrosis factor-alpha blocking agents. There are several side effects reported in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozkan, Hakan, Cetinkaya, Ahmet Seckin, Yildiz, Tekin, Bozat, Tahsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732623/
https://www.ncbi.nlm.nih.gov/pubmed/23970991
http://dx.doi.org/10.1155/2013/985914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732623/
https://www.ncbi.nlm.nih.gov/pubmed/23970991
http://dx.doi.org/10.1155/2013/985914

Ejemplares similares